<DOC>
	<DOC>NCT01173575</DOC>
	<brief_summary>This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection. Primary objective: â€¢ To assess clinical and microbiological efficacy of FOM in patients with bacterial infection. Secondary objectives: - To determine the rate and severity of unexpected adverse events. - To determine the mean duration of therapy with FOM in patients with bacterial infection. Study design: Multi-center, non-interventional study</brief_summary>
	<brief_title>Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection</brief_title>
	<detailed_description>Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J&amp;P MEDICAL RESEARCH LTD.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<criteria>Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>